Terazosin Hydrochloride
- Product NDC
- 49999-227
- 11-digit product format
- 499990227
- Labeler code
- 49999
- Product ID
- 49999-227_0a1efcd1-41a5-4914-86c3-73c0e3d82c23
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Quality Care Products LLC
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2009-07-01
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49999-227-30 | 49999022730 | 30 CAPSULE in 1 BOTTLE (49999-227-30) | 30 capsule | 2009-07-01 | 0000-00-00 | No | No | Current |
| 49999-227-60 | 49999022760 | 60 CAPSULE in 1 BOTTLE (49999-227-60) | 60 capsule | 2009-07-01 | 0000-00-00 | No | No | Current |
| 49999-227-90 | 49999022790 | 90 CAPSULE in 1 BOTTLE (49999-227-90) | 90 capsule | 2009-07-01 | 0000-00-00 | No | No | Current |